Esther M. Van Egmond
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Selective lymphodepletion underlies the efficacy of horse anti-thymocyte globulin-based immunosuppressive therapy in aplastic anemia.
Journal: Haematologica
Published: October 03, 2025
Inflammation-driven variability in drug metabolism: Insights from voriconazole treatment of HSCT recipients.
Journal: British journal of clinical pharmacology
Published: June 19, 2025
Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion.
Journal: Transplantation and cellular therapy
Published: October 13, 2022
Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation.
Journal: Cytotherapy
Published: May 03, 2020
Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft.
Journal: Transplant immunology
Published: March 22, 2019
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II study.
Journal: Leukemia
Published: March 21, 2019
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
Journal: Frontiers in immunology
Published: October 10, 2018
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.
Journal: American journal of hematology
Published: July 25, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026